Your browser doesn't support javascript.
loading
Differences in somatic TP53 mutation type in breast tumors by race and receptor status.
Pollock, Nijole C; Ramroop, Johnny R; Hampel, Heather; Troester, Melissa A; Conway, Kathleen; Hu, Jennifer J; Freudenheim, Jo L; Olopade, Olufunmilayo I; Huo, Dezheng; Ziv, Elad; Neuhausen, Susan L; Stevens, Patrick; McElroy, Joseph Paul; Toland, Amanda Ewart.
Afiliação
  • Pollock NC; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
  • Ramroop JR; Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
  • Hampel H; OSU Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
  • Troester MA; Division of Human Genetics, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Conway K; Department of Epidemiology and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Hu JJ; Department of Epidemiology and the Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Freudenheim JL; Department of Public Health Sciences, Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL, USA.
  • Olopade OI; Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.
  • Huo D; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
  • Ziv E; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
  • Neuhausen SL; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Stevens P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • McElroy JP; Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.
  • Toland AE; Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, USA.
Breast Cancer Res Treat ; 192(3): 639-648, 2022 Apr.
Article em En | MEDLINE | ID: mdl-35286522
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína Supressora de Tumor p53 / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Proteína Supressora de Tumor p53 / Neoplasias de Mama Triplo Negativas Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos